Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
about
Time course and pattern of metastasis of cutaneous melanoma differ between men and womenA phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanomaHigh MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanomaTolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874]Results of systemic treatment of cutaneous melanoma in inoperable stage III and IVSurvivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysisA phase I study of high-dose calcitriol in combination with temozolomide for patients with metastatic melanoma.Does metastasectomy improve survival in patients with Stage IV melanoma? A cancer registry analysis of outcomes.A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response.Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study.Response rates of patients with metastatic melanoma to high-dose intravenous interleukin-2 after prior exposure to alpha-interferon or low-dose interleukin-2.Loss of the eukaryotic initiation factor 3f in melanoma.Small molecules and targeted therapies in distant metastatic disease.WT1 shRNA delivery using transferrin-conjugated PEG liposomes in an in vivo model of melanoma.Systemic therapy of non-resectable metastatic melanoma.Profile of selumetinib and its potential in the treatment of melanoma.Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application.Clinicopathological characteristics of malignant melanomas of the skin and gastrointestinal tract.
P2860
Q21134734-F92CCEC8-9B24-4DC0-984D-A82026B77C14Q24658533-AF51285C-0434-43D6-AEBD-6C5929462D78Q27498879-68160BCE-F67E-4625-9B86-206F4F21A0B4Q33234917-27896F4A-04EF-4AB4-9E9E-B515CF2C060EQ33408564-CF86B41C-BA05-4988-A1C5-91BD60848511Q33887196-F3C42C16-1E3B-463C-B2E6-16A295E29B48Q34170003-FED2EA75-8A96-466B-ABDE-13D111FCC396Q34809620-020849BE-CCFB-43AA-A1EE-2D72743B453BQ35422126-711A88CD-B972-46F7-9388-05812393629DQ35602183-9E69D5FF-1438-469F-8BBE-4EEDA53051EBQ36162586-58F09248-E897-4D39-8BB4-AA4203548F53Q36826045-186BD6A6-A66A-4489-858E-7D300D77E050Q37083955-08982D16-CC90-4F42-8183-222251F9F337Q37555793-C7D44ABB-B857-4137-ABE2-9DA682EF9098Q37582083-56AB795C-89FF-49F0-B2AE-171644E171F1Q38166572-6BF826A8-8DEE-4A28-A313-66719C81759BQ38256348-F764A839-4EEC-4C19-957D-178E8C531D21Q42798738-2DED30FC-81CB-442A-8A14-353FC986E5FDQ55686334-344FA38E-12D0-4176-8796-13911B1C64DA
P2860
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
@ast
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
@en
type
label
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
@ast
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
@en
prefLabel
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
@ast
Duration of survival for disseminated malignant melanoma: results of a meta-analysis.
@en
P2093
P1433
P1476
Duration of survival for disseminated malignant melanoma: results of a meta-analysis
@en
P2093
P407
P577
2000-02-01T00:00:00Z